Correction: Upregulation of microRNA135a-3p and death receptor 5 plays a critical role in Tanshinone I sensitized prostate cancer cells to TRAIL induced apoptosis

Eun Ah Shin; Eun Jung Sohn; Gunho Won; Jeong-Un Choi; Myongsuk Jeong; Bonglee Kim; Min-Jeong Kim; Sung-Hoon Kim

doi:10.18632/oncotarget.25777

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Upregulation of microRNA135a-3p and death receptor 5 plays a critical role in Tanshinone I sensitized prostate cancer cells to TRAIL induced apoptosis

PDF | How to cite

Oncotarget. 2018; 9:30720-30720. https://doi.org/10.18632/oncotarget.25777

Metrics: PDF 1399 views | ?

Eun Ah Shin^1,*, Eun Jung Sohn^1,*, Gunho Won¹, Jeong-Un Choi¹, Myongsuk Jeong¹, Bonglee Kim¹, Min-Jeong Kim¹ and Sung-Hoon Kim¹

¹Cancer Preventive Material Development Research Center, College of Oriental Medicine, Kyung Hee University, Seoul, South Korea
^*These authors equally contributed to this work

Published: July 17, 2018

This article has been corrected: An identical set of Bcl2 bands was mistakenly shown for both the PC-3 and DU145 cells in Figure 2C. The corrected figure for DU145 cells is given below. The authors provided an original Western blot for DU145 cells and declare that these corrections do not change the results or conclusions of this paper.

Original article: Oncotarget. 2014; 5:5624-5636. DOI: https://doi.org/10.18632/oncotarget.2152.

Figure 2: (C) Effect of Tanshinone I and/or TRAIL on apoptotic proteins in PC-3 and DU145 cells. PC-3 and DU145 cells were treated in the absence or presence of Tanshinone I (20, 40 μM) and/ or TRAIL (25 ng/ml) for 24 h. Western blotting was subjected for PARP, procaspase 8, procaspase 9, cleaved caspase3, Bcl-2, Bcl-xL, and β-Actin was used as the internal control.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25777

Publication Alerts

Corrections:

Correction: Upregulation of microRNA135a-3p and death receptor 5 plays a critical role in Tanshinone I sensitized prostate cancer cells to TRAIL induced apoptosis